Secret Antiperspirant Aerosol, Spray
FDA Recall NDC 37000-134
FDA Enforcement Report: View Recall Date, Reasons, and Safety Status
Active & Historical Enforcement Reports
The FDA has identified 2 recorded enforcement report(s) associated with Secret Antiperspirant (NDC 37000-134). A significant event, classified as Class II, was initiated on Nov 23, 2021 by The Procter & Gamble Manufacturing Company. The reported reason for this action was: "CGMP Deviation; manufactured at the same facility where other lots were found to be contaminated with benzene"
This specific recall has a current status of TERMINATED, indicating that the FDA considers the recall process finished or the product successfully recovered.
This specific recall has a current status of TERMINATED, indicating that the FDA considers the recall process finished or the product successfully recovered.
Reported Recall Events
November 2021 Class II Recall: CGMP Deviation; manufactured at the same facility where other lots were found to be contaminated with benzene
Recall Number
Class II Terminated
CGMP Deviation; manufactured at the same facility where other lots were found to be contaminated with benzene
Nov 23, 2021
Jan 24, 2024
unknown
Recall Profile & Regulatory Data
Event ID
89106
Classification
Class II
Enforcement Status
Terminated
Recalling Firm
The Procter & Gamble Company
Voluntary / Mandated
Voluntary: Firm initiated
Distribution Pattern
Nationwide USA and Puerto Rico, Canada, Guam, Northern Mariana Islands, American Samoa, Bhutan, Timor-Leste, Maldives, Fiji, US Virgin Islands, Trinidad, Peru, Saint Marteen, Bahamas, Costa Rica, Guatemala, Honduras, Panama, Belize, Santa Lucia, Aruba, Dominican Republic, Guyana
Termination Date
Oct 01, 2024
Product Description
Secret, powder fresh, (Aluminum chlorohydrate 24%), Anti-Perspirant/Deodorant, Topical spray can Net Wt., (a) 4OZ (113g), NDC 37000-134-11, UPC 0 37000 71109 4, (b) 6OZ (170g), NDC 37000-134-17, UPC 0 37000 71108 7; (c) twin pack-2 Topical spray cans, each can Net Wt. 6OZ (170g), NDC: 37000-134-01, UPC 0 37000 58690 6; Dist. by: Procter & Gamble, Cincinnati, OH 45202,
Batch or Lot Expiration Information
Lot# All lots with expiry through September 2023
Affected Packages Involved in this Recall
37000-134-11Product
37000-134-17Product
37000-134-01Product
Class I Terminated
Chemical contamination: presence of benzene
Nov 23, 2021
Jan 24, 2024
unknown
Recall Profile & Regulatory Data
Event ID
89106
Classification
Class I
Enforcement Status
Terminated
Recalling Firm
The Procter & Gamble Company
Voluntary / Mandated
Voluntary: Firm initiated
Distribution Pattern
Nationwide USA and Puerto Rico, Canada, Guam, Northern Mariana Islands, American Samoa, Bhutan, Timor-Leste, Maldives, Fiji, US Virgin Islands, Trinidad, Peru, Saint Marteen, Bahamas, Costa Rica, Guatemala, Honduras, Panama, Belize, Santa Lucia, Aruba, Dominican Republic, Guyana
Termination Date
Oct 01, 2024
Product Description
Secret, powder fresh, Aluminum chlorohydrate 24%, Anti-Perspirant/Deodorant, Topical spray can Net Wt., (a) 4OZ (113g), NDC 37000-134-11, UPC 0 37000 71109 4, (b) 6OZ (170g), NDC 37000-134-17, UPC 0 37000 71108 7; (c) twin pack-2 each can Net Wt. 6OZ (170g), NDC: 37000-134-01, UPC 0 37000 58690 6; Distr. by: Procter & Gamble, Cincinnati, OH 45202
Batch or Lot Expiration Information
Lot# : (a &b) 00701458SJ, 00861458SA, 00871458SA, Exp 1/28/2022; 00921458SK, Exp 3/31/2022; 01701458SJ, 01711458SE, Exp 5/31/2022; 03431458SA, 03441458SA, 03531458SM, Exp 11/30/2022; 10681458SJ, 10691458SA, 10701458SA, 10781458SE, 10811458SJ, Exp 2/28/2023; 11701458SH, 11711458SH, 11721458SG, Exp 5/31/2023; 12181458SD, Exp 7/31/23; 12631458SH,12641458SB, 12651458SE, Exp 8/31/23; 10301458SA,Exp 12/31/22; 10921458SJ, 10931458SA, 11191458SJ, Exp 3/31/23; 11251458SB, 11421458SM, 11431458SB, Exp 4/30/2023; 11701458SH, 11711458SB, Exp 5/31/2023; 12101458SJ, 12121458SJ, Exp 6/30/2023 (c) 11711458SB, Exp 5/31/2023
Affected Packages Involved in this Recall
37000-134-11Product
37000-134-17Product
37000-134-01Product
About FDA Recall Enforcement Reports
FDA recall data documents classified recall actions associated with a product. Most recalls are limited to specific lots, batches, or package configurations rather than every unit of a drug.
If a recall is listed for an NDC, review the affected lot information and package details carefully. Patients and healthcare professionals should confirm whether a specific product in hand matches the lot or package information before assuming it is affected.
